A report on the March 15th China Central Television (CCTV) consumer rights day gala highlighted irregularities in the cosmetic medicine sector concerning exosome products. Currently, no exosome-based pharmaceutical products have been approved for market release in China.

In response, So Young stated that it has proactively responded to the non-compliant exosome products mentioned in the "315" gala report and has taken down the related items uploaded by merchants on its cosmetic medicine platform as a first step.

A customer service representative from Meituan said that the products involved in the report have been removed from its platform, adding that the company will actively follow the investigation's progress to protect consumer rights.